Clinical Trials Logo

Clinical Trial Summary

Placenta percreta is a life-threatening condition that patients are under risk of massive bleeding. It readily necessitates very complicated surgery even leads to mortality. Cesarean hysterectomy is the procedure that is acknowledged worldwide, however, recent studies discussing conservative treatment with segmental resections were published. Fetal extraction and segmental resection could be performed from same (single uterine incision) or two different (double uterine incision) incisions. In this study, the investigators aimed to evaluate the effectiveness and the results of double uterine incision.


Clinical Trial Description

n/a


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT02702024
Study type Interventional
Source Kanuni Sultan Suleyman Training and Research Hospital
Contact
Status Completed
Phase N/A
Start date January 2014

See also
  Status Clinical Trial Phase
Completed NCT06267599 - Bladder Suture in Uterus-Sparing Surgery and Hysterectomy for Placenta Percreta
Recruiting NCT03638024 - Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
Active, not recruiting NCT02784886 - Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta N/A
Completed NCT04213755 - ROTEM in Patients With Placenta Previa
Completed NCT02728232 - Internal Iliac Artery Ligation and Abnormally Invasive Placenta N/A